✦ LIBER ✦

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB–IVA carcinoma of the cervix: a Southwest Oncology Group study

✍ Scribed by Robert S. Lavey; P.Y. Liu; Benjamin E. Greer; William R. Robinson III; Pui C. Chang; Raymond B. Wynn; Marcel E. Conrad; Caroline Jiang; Maurie Markman; David S. Alberts

Book ID: 113959453
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 143 KB
Volume: 95
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2004.07.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to: Lavey, RS et al. Recombinan

Response to: Lavey, RS et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IB–IVA carcinoma of the cervix: a Southwest Oncology Group Study. Gynecol. Oncol. 95 (2004) 145–151

✍ Alexander Krafft; Thomas Hess 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Hyperbaric oxygen therapy for carcinoma

Hyperbaric oxygen therapy for carcinoma of the cervix—Stages IIB, IIIA, IIIB and IVA: Results of a randomized study by the radiation therapy oncology group

✍ Luther W. Brady; Henry P. Plenk; James A. Hanley; John R. Glassburn; Simon Krame 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 807 KB

Hyperbaric oxygen therapy for carcinoma

Hyperbaric oxygen therapy for carcinoma of the cervix stages IIB, IIIA, IIIB and IVA results of a randomized study by the radiation therapy oncology group

✍ Henry P. Plenk; Luther W. Brady; James A. Hanley; John R. Glassburn; Simon Krame 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 95 KB

A randomized trial of hydroxyurea (HD) v

A randomized trial of hydroxyurea (HD) vs misonidazole (Mi) adjunct to radiation therapy in Stages IIB, III, and IVA carcinoma of the cervix (CA CX): A gynecologic oncology group study

✍ F. Stehman; V. Jobson; B. Bundy; W. Fowler; C. Whitney 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Phase III, Open-Label, Randomized Study

Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix

✍ Duenas-Gonzalez, A.; Zarba, J. J.; Patel, F.; Alcedo, J. C.; Beslija, S.; Casano 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 167 KB